Volitionrx (VNRX) Cash from Operations (2011 - 2025)
Volitionrx (VNRX) posted Cash from Operations of 5491867.0 for Q4 2025, down 51.26% on a QoQ basis from 3630760.0 in Q3 2025, and down 1.11% year-over-year from 5553303.48 in Q4 2024.
Volitionrx (VNRX) Cash from Operations (2011 - 2025) Analysis & Trends
Volitionrx's Cash from Operations history runs 15 years deep, the most recent figure standing at 5491867.0 for Q4 2025.
- Quarterly Cash from Operations fell 1.11% year-over-year to 5491867.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 19683334.0 (up 23.98% YoY) and the FY2025 annual result came in at 19683334.0, up 23.98% from the prior year.
- Cash from Operations was 5491867.0 for Q4 2025 at Volitionrx, down from 3630760.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 6447736.0 in Q4 2023 and bottomed at 8744744.0 in Q1 2023.
- A 5-year average of 4988580.9 and a median of 5647777.0 in 2022 frame the typical range for Cash from Operations.
- Peak annual rise in Cash from Operations reached 211.1% in 2023, while the deepest fall reached 342.21% in 2023.
- Volitionrx's Cash from Operations stood at 4409404.0 in 2021, then plunged by 31.62% to 5803687.0 in 2022, then soared by 211.1% to 6447736.0 in 2023, then slumped by 184.24% to 5431775.0 in 2024, then fell by 1.11% to 5491867.0 in 2025.
- Business Quant data shows VNRX's Cash from Operations at 5491867.0 in Q4 2025, 3630760.0 in Q3 2025, and 6262689.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.32 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 581.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 2.57 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 348.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 43.80 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 525.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 220.10 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 290.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Volitionrx | 109,643.10 | -2.35 Mn | - | -5.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -5.49 Mn |
| Dec 31, 2025 | -5.49 Mn |
| Sep 30, 2025 | -3.63 Mn |
| Sep 30, 2025 | -3.63 Mn |
| Jun 30, 2025 | -6.26 Mn |
| Jun 30, 2025 | -6.26 Mn |
| Mar 31, 2025 | -4.30 Mn |
| Mar 31, 2025 | -4.30 Mn |
| Dec 31, 2024 | -5.43 Mn |
| Dec 31, 2024 | -5.43 Mn |
| Sep 30, 2024 | -5.39 Mn |
| Sep 30, 2024 | -5.39 Mn |
| Jun 30, 2024 | -6.73 Mn |
| Jun 30, 2024 | -6.73 Mn |
| Mar 31, 2024 | -8.34 Mn |
| Mar 31, 2024 | -8.34 Mn |
| Dec 31, 2023 | 6.45 Mn |
| Dec 31, 2023 | 6.45 Mn |
| Sep 30, 2023 | -8.42 Mn |
| Sep 30, 2023 | -8.42 Mn |